DRUG-THERAPY - DRUGS AND THYROID-FUNCTION

被引:230
作者
SURKS, MI [1 ]
SIEVERT, R [1 ]
机构
[1] ALBERT EINSTEIN COLL MED, BRONX, NY 10467 USA
关键词
D O I
10.1056/NEJM199512213332507
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Testing of thyroid function is common in clinical practice. Many patients who are tested, including those who have or are receiving treatment for thyroid disease, take medications that may affect thyroid function. Therefore, the possible effect of these drugs both on the results of thyroid-function tests and on the effectiveness of treatment must always be considered in decisions regarding patient care. The pathways of thyroid hormone synthesis, secretion, transport in the circulation, and metabolism offer numerous targets for drug interaction (Figure 1 and Figure 2). Normal thyroid secretion depends on thyrotropin (TSH). Secretion of TSH is, in turn, inhibited by thyroid hormones. © 1995, Massachusetts Medical Society. All rights reserved.
引用
收藏
页码:1688 / 1694
页数:7
相关论文
共 96 条
[1]   INCREASED DOPAMINERGIC ACTIVITY INHIBITS BASAL AND METOCLOPRAMIDE-STIMULATED PROLACTIN AND THYROTROPIN SECRETION [J].
AGNER, T ;
HAGEN, C ;
ANDERSEN, AN ;
DJURSING, H .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 62 (04) :778-782
[2]   DECREASED LEVOTHYROXINE REQUIREMENT IN WOMEN WITH HYPOTHYROIDISM DURING ANDROGEN THERAPY FOR BREAST-CANCER [J].
ARAFAH, BM .
ANNALS OF INTERNAL MEDICINE, 1994, 121 (04) :247-251
[3]   THYROXINE TRANSPORT AND METABOLISM IN METHADONE AND HEROIN-ADDICTS [J].
AZIZI, F ;
VAGENAKIS, AG ;
PORTNAY, GI ;
BRAVERMAN, LE ;
INGBAR, SH .
ANNALS OF INTERNAL MEDICINE, 1974, 80 (02) :194-199
[4]   RECENT ACHIEVEMENTS IN STUDIES ON THYROID HORMONE-BINDING PROTEINS [J].
BARTALENA, L .
ENDOCRINE REVIEWS, 1990, 11 (01) :47-64
[5]   SERUM INTERLEUKIN-6 IN AMIODARONE-INDUCED THYROTOXICOSIS [J].
BARTALENA, L ;
GRASSO, L ;
BROGIONI, S ;
AGHINILOMBARDI, F ;
BRAVERMAN, LE ;
MARTINO, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (02) :423-427
[6]   VARIATIONS IN THYROID-HORMONE TRANSPORT PROTEINS AND THEIR CLINICAL IMPLICATIONS [J].
BARTALENA, L ;
ROBBINS, J .
THYROID, 1992, 2 (03) :237-245
[7]   REVERSIBILITY OF THYROID-DYSFUNCTION INDUCED BY RECOMBINANT ALPHA-INTERFERON IN CHRONIC HEPATITIS-C [J].
BAUDIN, E ;
MARCELLIN, P ;
POUTEAU, M ;
COLASLINHART, N ;
LEFLOCH, JP ;
LEMMONIER, C ;
BENHAMOU, JP ;
BOK, B .
CLINICAL ENDOCRINOLOGY, 1993, 39 (06) :657-661
[8]   DECREASED RECEPTOR-BINDING OF BIOLOGICALLY INACTIVE THYROTROPIN IN CENTRAL HYPOTHYROIDISM - EFFECT OF TREATMENT WITH THYROTROPIN-RELEASING-HORMONE [J].
BECKPECCOZ, P ;
AMR, S ;
MENEZESFERREIRA, MM ;
FAGLIA, G ;
WEINTRAUB, BD .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (17) :1085-1090
[9]  
BEEX L, 1977, CANCER TREAT REP, V61, P1291
[10]  
BENRAFAEL Z, 1987, FERTIL STERIL, V48, P318